1
Stanley M Crain, Ke fei Shen, John A Kessler, Stuart C Apfel: Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, December 17, 1996: US05585348 (83 worldwide citation)

This invention relates to a method of preventing hyperalgesia and other undesirable side-effects associated with the administration of growth factor, including nerve growth factor, utilizing an antagonist capable of inactivating excitatory opioid receptor-mediated functions on neurons in the nocicep ...


2
Michael E Lewis, Stuart C Apfel, John A Kessler: Prevention and treatment of peripheral neuropathy. Cephalon, Albert Einstein College of Medicine of Yeshiva Univ, Fish & Richardson P C, July 15, 1997: US05648335 (64 worldwide citation)

The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.


3
Michael E Lewis, Stuart C Apfel, John A Kessler: Prevention and treatment of peripheral neuropathy. Cephalon, Albert Einstein College of Medicine of Yeshiva University, Fish & Richardson P C, October 29, 1996: US05569648 (41 worldwide citation)

The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.


4
Michael E Lewis, Stuart C Apfel, John A Kessler: Prevention and treatment of peripheral neuropathy. May 30, 1995: US05420112 (34 worldwide citation)

The invention features a method of preventing or treating a peripheral neuropathy that results from a systemic disease (e.g., post-polio syndrome) or a toxic agent (e.g., a chemotherapeutic agent), and that is not caused by an abnormal insulin level in a mammal. The method involves administering a n ...


5
Michael E Lewis, Stuart C Apfel, John A Kessler: Prevention and treatment of peripheral neuropathy. Cephalon, Albert Einstein College of Medicine of Yeshiva University, Fish & Richardson P C, May 27, 1997: US05633228 (24 worldwide citation)

The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.


6
John A Kessler, Stuart C Apfel: Use of NGF growth factors to treat drug-induced neuropathy. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, February 18, 1997: US05604202 (22 worldwide citation)

This invention relates to the use of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor ...


7
John A Kessler, Stuart C Apfel: Use of growth factors to treat drug-inducted neuropathy. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, January 4, 2000: US06011004 (15 worldwide citation)

This invention relates to the use of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor ...